INSACOG

insacog-logo
  • Slider image
  • Slider image
  • Slider image
  • Slider image
  • Slider image
  • Slider image
  • Slider image
  • Slider image
  • Slider image
  • Slider image
  • Slider image
  • Slider image
  • Slider image
  • Slider image
  • Slider image

The Indian SARS-CoV-2 Genomics Consortium (INSACOG), jointly initiated by the Union Health Ministry of Health, and Department of Biotechnology (DBT) with Council for Scientific & Industrial Research (CSIR) and Indian Council of Medical Research (ICMR), is a consortium of 54 laboratories to monitor the genomic variations in the SARS-CoV-2. INSACOG is a multi-laboratory, multi-agency, Pan-India network to monitor genomic variations in the SARS-CoV-2 by a sentinel sequencing effort which is facilitated by the National Centre for Disease Control (NCDC), Delhi involving the Central Surveillance Unit (CSU) under Integrated Disease Surveillance Programme (IDSP). The data from the genome sequencing laboratories is being analyzed as per the field data trends to study the linkages (if any) between the genomic variants and epidemiological trends. This helps to understand super spreader events, outbreaks and strengthen public health interventions across the country to help in breaking the chains of transmission. Linking this data with the IDSP data and patient’s symptoms allows a better understanding of the viral infection dynamics, morbidity and mortality trends. Further, the data can be linked with host genomics, immunology, clinical outcomes and risk factors for a more comprehensive outlook. In addition, as the reported cases of reinfection and vaccine breakthroughs samples are also being sequencing assumes. The consortium is actively working towards establishing a systematic correlation between genome sequencing and clinical outcomes. The consortium in its attempt to answer questions related to host immune response, long term effects in immunity of COVID infected individuals, has established a Hospital network across the country. This arm of the consortium aims to study clinical correlations in mild Vs severe cases of COVID, longitudinal study to understand long term post-COVID complications and change in immunity. Additionally, the consortium is also working to expand to sewage surveillance as a quick and early detection tool of assess the spread of variants in a hotspot locality of increased positivity..

INSACOG: Updates

INSACOG: Updates
S.No Title Details
1 SOPs for Joining INSACOG Network PDF icon View Details
2 Q&A on Indian SARS-CoV-2 Genomics Consortium (INSACOG) View
3 Mutations in SARS-CoV-2 PDF icon View
4 Myths vs Facts View More
5 Press briefing on the actions taken, preparedness and updates on COVID-19, Dated: 25.06.2021 View More
6 INSACOG- Institutions and Contact person list PDF icon View
7 Department of Biotechnology organizes Public Webinar on the “Genome Sequencing of SARS-CoV-19” View
8 Public Webinar on Genome Sequencing of SARS-CoV-19 View